Todos Medical Ltd. (TOMDF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 14.05 Million USD | 2.85% |
| 2021 | 13.66 Million USD | -12.66% |
| 2020 | 15.65 Million USD | 345.21% |
| 2019 | 3.51 Million USD | 154.93% |
| 2018 | 1.37 Million USD | 3.08% |
| 2017 | 1.33 Million USD | 83.51% |
| 2016 | 728.88 Thousand USD | -12.29% |
| 2015 | 830.98 Thousand USD | 107.31% |
| 2014 | 400.84 Thousand USD | 4.98% |
| 2013 | 381.81 Thousand USD | 148977.78% |
| 2012 | 256.12 USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2022 Q4 | 3.28 Million USD | 38.33% |
| 2022 Q2 | 2.98 Million USD | -29.96% |
| 2022 FY | 14.05 Million USD | 2.85% |
| 2022 Q1 | 4.26 Million USD | 41.38% |
| 2022 Q3 | 2.37 Million USD | -20.45% |
| 2021 Q1 | 3.63 Million USD | 74.67% |
| 2021 FY | 13.66 Million USD | -12.66% |
| 2021 Q4 | 3.01 Million USD | 23.67% |
| 2021 Q3 | 2.43 Million USD | -1.81% |
| 2021 Q2 | 2.48 Million USD | -31.62% |
| 2020 Q1 | 1.18 Million USD | 0.0% |
| 2020 FY | 15.65 Million USD | 345.21% |
| 2020 Q4 | 2.07 Million USD | -80.47% |
| 2020 Q3 | 10.64 Million USD | 511.9% |
| 2020 Q2 | 1.74 Million USD | 46.92% |
| 2019 FY | 3.51 Million USD | 154.93% |
| 2018 FY | 1.37 Million USD | 3.08% |
| 2017 FY | 1.33 Million USD | 83.51% |
| 2016 FY | 728.88 Thousand USD | -12.29% |
| 2015 Q4 | 141 Thousand USD | -0.0% |
| 2015 Q3 | 141 Thousand USD | -47.44% |
| 2015 Q2 | 268.26 Thousand USD | 0.0% |
| 2015 Q1 | 268.26 Thousand USD | 322.58% |
| 2015 FY | 830.98 Thousand USD | 107.31% |
| 2014 Q1 | 97.54 Thousand USD | 0.0% |
| 2014 Q4 | 63.48 Thousand USD | -0.0% |
| 2014 Q2 | 97.55 Thousand USD | 0.0% |
| 2014 FY | 400.84 Thousand USD | 4.98% |
| 2014 Q3 | 63.48 Thousand USD | -34.92% |
| 2013 FY | 381.81 Thousand USD | 148977.78% |
| 2012 FY | 256.12 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -1240.133% |
| Arrayit Corporation | 6.19 Million USD | -126.831% |
| Atlantic International Corp. | 5.57 Million USD | -152.013% |
| Biocept, Inc. | 29.4 Million USD | 52.185% |
| Bioqual, Inc. | 7.44 Million USD | -88.729% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -1720.65% |
| DermTech, Inc. | 104.01 Million USD | 86.485% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 91.557% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 37.862% |
| iMD Companies, Inc. | 151.8 Thousand USD | -9160.321% |
| IDenta Corp. | 662.97 Thousand USD | -2020.442% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 30.516% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -36056.477% |
| InVitro International | 661.32 Thousand USD | -2025.736% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -98.056% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -24091.217% |
| Medical Imaging Corp. | 1.91 Million USD | -635.188% |
| NovelStem International Corp. | 3.53 Million USD | -297.366% |
| Optigenex Inc. | 1.28 Million USD | -991.571% |
| PharmChem, Inc. | 2.93 Million USD | -379.594% |
| Proteome Sciences plc | 3.26 Million USD | -330.171% |
| Response Genetics, Inc | 25.31 Million USD | 44.476% |
| Rennova Health, Inc. | 7.67 Million USD | -83.1% |
| RushNet, Inc. | 1.78 Million USD | -685.662% |
| ScreenPro Security Inc. | 3.23 Million USD | -334.035% |
| Stella Diagnostics Inc. | 11.42 Million USD | -23.025% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -91.447% |